Financial Partners Group (Kansas)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $219K | Sell |
|
|||||
|
2024
Q3 | $240K | Sell |
|
|||||
|
2024
Q2 | $244K | Sell |
|
|||||
|
2024
Q1 | $269K | Hold |
|
|||||
|
2023
Q4 | $253K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $230K | Sell |
|
|||||
|
2023
Q1 | $260K | Hold |
|
|||||
|
2022
Q4 | $292K | Sell |
|
|||||
|
2022
Q3 | $318K | Sell |
|
|||||
|
2022
Q2 | $318K | Sell |
|
|||||
|
2022
Q1 | $405K | Sell |
|
|||||
|
2021
Q4 | $474K | Sell |
|
|||||
|
2021
Q3 | $662K | Sell |
|
|||||
|
2021
Q2 | $719K | Sell |
|
|||||
|
2021
Q1 | $763K | Sell |
|
|||||
|
2020
Q4 | $871K | Buy |
|
|||||
|
2020
Q3 | $644K | Buy |
|
|||||
|
2020
Q2 | $646K | Buy |
|
|||||
|
2020
Q1 | $423K | Sell |
|
|||||
|
2019
Q4 | $533K | Sell |
|
|||||
|
2019
Q3 | $469K | Sell |
|
|||||
|
2019
Q2 | $557K | Sell |
|
|||||
|
2019
Q1 | $600K | Hold |
|
|||||
|
2018
Q4 | $476K | Sell |
|
|||||
|
2018
Q3 | $661K | Hold |
|
|||||
|
2018
Q2 | $656K | Hold |
|
|||||
|
2018
Q1 | $604K | Sell |
|
|||||
|
2017
Q4 | $591K | Buy |
|